Inventor
WARNER JUSTIN E
US12 patents
Patents
12 patentsUS6979549B2Dec 27, 2005
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a CLLD8 protein
RIGEL PHARMACEUTICALS INC5 citations73
US7425418B2Sep 16, 2008
Compounds that modulate processes associated with IgE production
RIGEL PHARMACEUTICALS INC3 citations62
US7378251B2May 27, 2008
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa protein
RIGEL PHARMACEUTICALS INC2 citations62
US7604951B2Oct 20, 2009
Method for identifying compounds that modulate RXR associated processes with IgE production
RIGEL PHARMACEUTICALS INC1 citations51
US7598050B2Oct 6, 2009
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein
RIGEL PHARMACEUTICALS INC1 citations51
US7563585B2Jul 21, 2009
Methods of assaying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa protein (TXNL)
RIGEL PHARMACEUTICALS INC0 citations51
US7422867B2Sep 9, 2008
Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein
RIGEL PHARMACEUTICALS INC0 citations51
US7374894B2May 20, 2008
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein
RIGEL PHARMACEUTICALS INC0 citations51
US7241581B2Jul 10, 2007
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a c-MYC protein
RIGEL PHARMACEUTICALS INC0 citations51
US7208289B2Apr 24, 2007
Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein
RIGEL PHARMACEUTICALS INC0 citations51
US7189523B2Mar 13, 2007
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a B-cell associated protein
RIGEL PHARMACEUTICALS INC0 citations51
US7141434B2Nov 28, 2006
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing an adenosine kinase
RIGEL PHARMACEUTICALS INC0 citations51